FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031214697> ?p ?o ?g. }

• W2031214697 endingPage "B27" @default.
• W2031214697 startingPage "B21" @default.
• W2031214697 abstract "Abstract Increased levels of plasma high-density lipoprotein (HDL) cholesterol have been described after exposure to different dietary (such as ethanol) and environmental (such as chlorinated pesticides) factors as well as intense physical training. Several lipid-lowering drugs have also been shown to elevate HDL cholesterol. These findings are of particular interest, because adult levels of the putatively protective lipoprotein fraction appear not to be regulated by genetic factors. Four hypolipidemic drugs are herein considered, all of which reportedly elevate HDL cholesterolemia. Two of them, bezafibrate and fenofibrate, belong to the class of “fibrate” derivatives; nicotinic acid (NA) and etofibrate (E) show some similarities, E being the chemical association between nicotinic acid and clofibrate. In most studies, bezafibrate (B), with a very short half-life (2.1 hours), has induced an HDL cholesterol elevation of about 20%, both in types II and IV hyperlipidemic patients; it is controversial whether HDL2 rather than HDL3 levels are elevated by B. Fenofibrate (F) shows prolonged plasma half-life in man (>21 hours) and markedly increases HDL cholesterol levels, particularly in type IV patients; data are less homogeneous in type IIA and IIB cohorts. It appears that F may increase apoprotein C-II levels in very low density lipoproteins, possibly an index of stimulated lipoprotein lipase activity. Both B and F may behave as “catabolic agents,” stimulating the breakdown of triglyceride-rich lipoproteins and the transfer of surface components (free cholesterol) to HDL. A different case may be that of NA, which prevents the decrease of HDL cholesterol induced by carbohydrate-rich diets in volunteers. NA reduces the catabolism of HDL and markedly increases (300% or more) the HDL 2 HDL 3 ratio in both volunteers and type IV patients, but not in type IIB patients. Whether, in addition to a “sparing” action on HDL, NA may also increase HDL levels by stimulating lipoprotein lipase activity is being disrupted. Finally, E may increase HDL cholesterol by 10% or more while exerting significant hypocholesterolemic activity. This compound is of interest because it may stimulate the release of prostacyclin from the arterial wall; prostacyclin may be derived from HDL phospholipids, unusually rich in arachidonic acid. This observation may offer another clue to the understanding of the mode of arterial protection exerted by HDL." @default.
• W2031214697 created "2016-06-24" @default.
• W2031214697 creator A5000676702 @default.
• W2031214697 creator A5012961676 @default.
• W2031214697 creator A5064838089 @default.
• W2031214697 date "1983-08-01" @default.
• W2031214697 modified "2023-09-26" @default.
• W2031214697 title "Influence of bezafibrate, fenofibrate, nicotinic acid and etofibrate on plasma high-density lipoprotein levels" @default.
• W2031214697 cites W119199256 @default.
• W2031214697 cites W1580303209 @default.
• W2031214697 cites W173802464 @default.
• W2031214697 cites W1892331455 @default.
• W2031214697 cites W1970571463 @default.
• W2031214697 cites W1971858258 @default.
• W2031214697 cites W1972391756 @default.
• W2031214697 cites W1976744580 @default.
• W2031214697 cites W1981670728 @default.
• W2031214697 cites W1982379751 @default.
• W2031214697 cites W1986214289 @default.
• W2031214697 cites W1988220724 @default.
• W2031214697 cites W1989799772 @default.
• W2031214697 cites W1993823831 @default.
• W2031214697 cites W1994967652 @default.
• W2031214697 cites W2001642792 @default.
• W2031214697 cites W2002531412 @default.
• W2031214697 cites W2008054802 @default.
• W2031214697 cites W2023320777 @default.
• W2031214697 cites W2026672982 @default.
• W2031214697 cites W2028679249 @default.
• W2031214697 cites W2029107159 @default.
• W2031214697 cites W2030768867 @default.
• W2031214697 cites W2031538309 @default.
• W2031214697 cites W2031563408 @default.
• W2031214697 cites W2033113181 @default.
• W2031214697 cites W2033715856 @default.
• W2031214697 cites W2037438512 @default.
• W2031214697 cites W2039813978 @default.
• W2031214697 cites W2042094006 @default.
• W2031214697 cites W2055384683 @default.
• W2031214697 cites W2060127696 @default.
• W2031214697 cites W2065173763 @default.
• W2031214697 cites W2066597748 @default.
• W2031214697 cites W2068316653 @default.
• W2031214697 cites W2078362634 @default.
• W2031214697 cites W2082655430 @default.
• W2031214697 cites W2085014447 @default.
• W2031214697 cites W2085923590 @default.
• W2031214697 cites W2089632613 @default.
• W2031214697 cites W2094210881 @default.
• W2031214697 cites W2112325638 @default.
• W2031214697 cites W2146394484 @default.
• W2031214697 cites W2152651023 @default.
• W2031214697 cites W2199595243 @default.
• W2031214697 cites W2336559915 @default.
• W2031214697 cites W2403849884 @default.
• W2031214697 cites W2415682701 @default.
• W2031214697 cites W2433370127 @default.
• W2031214697 cites W2436220393 @default.
• W2031214697 cites W2468487753 @default.
• W2031214697 cites W2779427821 @default.
• W2031214697 cites W2902460802 @default.
• W2031214697 cites W2412011786 @default.
• W2031214697 doi "https://doi.org/10.1016/0002-9149(83)90653-7" @default.
• W2031214697 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/6351577" @default.
• W2031214697 hasPublicationYear "1983" @default.
• W2031214697 type Work @default.
• W2031214697 sameAs 2031214697 @default.
• W2031214697 citedByCount "10" @default.
• W2031214697 crossrefType "journal-article" @default.
• W2031214697 hasAuthorship W2031214697A5000676702 @default.
• W2031214697 hasAuthorship W2031214697A5012961676 @default.
• W2031214697 hasAuthorship W2031214697A5064838089 @default.
• W2031214697 hasConcept C126322002 @default.
• W2031214697 hasConcept C134018914 @default.
• W2031214697 hasConcept C164705383 @default.
• W2031214697 hasConcept C170493617 @default.
• W2031214697 hasConcept C188987157 @default.
• W2031214697 hasConcept C2776362216 @default.
• W2031214697 hasConcept C2778110834 @default.
• W2031214697 hasConcept C2778163477 @default.
• W2031214697 hasConcept C2779496979 @default.
• W2031214697 hasConcept C2779745421 @default.
• W2031214697 hasConcept C2780072125 @default.
• W2031214697 hasConcept C2993401043 @default.
• W2031214697 hasConcept C71924100 @default.
• W2031214697 hasConceptScore W2031214697C126322002 @default.
• W2031214697 hasConceptScore W2031214697C134018914 @default.
• W2031214697 hasConceptScore W2031214697C164705383 @default.
• W2031214697 hasConceptScore W2031214697C170493617 @default.
• W2031214697 hasConceptScore W2031214697C188987157 @default.
• W2031214697 hasConceptScore W2031214697C2776362216 @default.
• W2031214697 hasConceptScore W2031214697C2778110834 @default.
• W2031214697 hasConceptScore W2031214697C2778163477 @default.
• W2031214697 hasConceptScore W2031214697C2779496979 @default.
• W2031214697 hasConceptScore W2031214697C2779745421 @default.
• W2031214697 hasConceptScore W2031214697C2780072125 @default.
• W2031214697 hasConceptScore W2031214697C2993401043 @default.
• W2031214697 hasConceptScore W2031214697C71924100 @default.

• next